serw-MX  [xml]  
 


    
 DeCS Categories

D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.706 Protective Agents .
D27.720 Specialty Uses of Chemicals .
D27.720.799 Protective Agents .
E01 Diagnosis .
E01.370 Diagnostic Techniques and Procedures .
E01.370.225 Clinical Laboratory Techniques .
E01.370.225.124 Clinical Chemistry Tests .
E01.370.225.124.200 Clinical Enzyme Tests .
E01.370.225.562 Genetic Testing .
E02 Therapeutics .
E02.190 Complementary Therapies .
E02.190.755 Phytotherapy .
E02.565 Hyperthermia, Induced .
E02.565.280 Diathermy .
E02.565.280.945 Ultrasonic Therapy .
E05 Investigative Techniques .
E05.196 Chemistry Techniques, Analytical .
E05.196.427 Enzyme Assays .
E05.196.427.200 Clinical Enzyme Tests .
E05.200 Clinical Laboratory Techniques .
E05.200.124 Clinical Chemistry Tests .
E05.200.124.200 Clinical Enzyme Tests .
E05.200.562 Genetic Testing .
E05.318 Epidemiologic Methods .
E05.318.760 Epidemiologic Study Characteristics .
E05.318.760.500 Epidemiologic Studies .
E05.318.760.500.750 Cohort Studies .
E05.337 Evaluation Studies as Topic .
E05.337.800 Product Surveillance, Postmarketing .
E05.337.800.800 Prescription Drug Monitoring Programs .
E05.393 Genetic Techniques .
E05.393.435 Genetic Testing .
H02 Health Occupations .
H02.403 Medicine .
H02.403.810 Specialties, Surgical .
H02.403.810.300 General Surgery .
N02 Health Care Facilities, Manpower, and Services .
N02.421 Health Services .
N02.421.308 Genetic Services .
N02.421.308.430 Genetic Testing .
N02.421.668 Pharmaceutical Services .
N02.421.668.320 Drug Information Services .
N02.421.668.320.600 Prescription Drug Monitoring Programs .
N02.421.726 Preventive Health Services .
N02.421.726.233 Diagnostic Services .
N02.421.726.233.221 Genetic Testing .
N05 Health Care Quality, Access, and Evaluation .
N05.715 Quality of Health Care .
N05.715.350 Epidemiologic Factors .
N05.715.350.075 Age Factors .
N05.715.350.075.100 Age of Onset .
N05.715.360 Health Care Evaluation Mechanisms .
N05.715.360.775 Epidemiologic Study Characteristics .
N05.715.360.775.175 Epidemiologic Studies .
N05.715.360.775.175.250 Cohort Studies .
N06 Environment and Public Health .
N06.850 Public Health .
N06.850.490 Epidemiologic Factors .
N06.850.490.250 Age Factors .
N06.850.490.250.100 Age of Onset .
N06.850.520 Epidemiologic Methods .
N06.850.520.450 Epidemiologic Study Characteristics .
N06.850.520.450.500 Epidemiologic Studies .
N06.850.520.450.500.750 Cohort Studies .
SP3 Population Studies in Public Health .
SP3.076 Vital Statistics .
SP3.076.187 Rates, Ratios and Proportions .
SP3.076.187.173 Mortality .
SP3.076.187.173.174 Occupational Mortality .
SP4 Environmental Health .
SP4.001 Health .
SP4.001.012 Environmental Illness .
SP4.001.012.153 Epidemiology .
SP4.001.012.153.239 Epidemiologic Studies .
SP4.001.012.153.239.135 Cohort Studies .
SP5 Epidemiology and Biostatistics .
SP5.001 Epidemiology .
SP5.001.012 Epidemiologic Studies .
SP5.001.012.038 Analytical Epidemiology .
SP5.001.012.038.049 Observational Studies as Topic .
SP5.001.012.038.049.035 Cohort Studies .
VS4 Environmental Health Surveillance .
VS4.002 Surveillance of the Workers Health .
VS4.002.001 Occupational Health .
VS4.002.001.002 Occupational Medicine .
VS4.002.001.002.004 Occupational Mortality .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Protective Agents .
Protective Drugs .
Agents, Protective .
Drugs, Protective .
Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. .
1.00
 
Age of Onset .
Age-at-Onset .
Age at Onset .
Onset Age .
The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual. .
0.44
 
Ultrasonic Therapy .
Therapy, Ultrasonic .
Therapies, Ultrasonic .
Ultrasonic Therapies .
The use of focused, high-frequency sound waves to produce local hyperthermia in certain diseased or injured parts of the body or to destroy the diseased tissue. .
0.42
 
Occupational Mortality .
Death due to work-related disease or injuries. .
0.41
 
Genetic Testing .
Genetic Screening .
Predictive Genetic Testing .
Predictive Testing, Genetic .
Testing, Genetic Predisposition .
Genetic Predictive Testing .
Genetic Screenings .
Genetic Testing, Predictive .
Predisposition Testing, Genetic .
Screening, Genetic .
Screenings, Genetic .
Testing, Genetic .
Testing, Genetic Predictive .
Testing, Predictive Genetic .
Genetic Predisposition Testing .
Genetic Screening .
Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing. .
0.41
 
Cohort Studies .
Analysis, Cohort .
Cohort Studies, Closed .
Cohort Studies, Historical .
Studies, Closed Cohort .
Studies, Concurrent .
Studies, Historical Cohort .
Analyses, Cohort .
Closed Cohort Study .
Cohort Analyses .
Cohort Study .
Cohort Study, Closed .
Cohort Study, Historical .
Concurrent Study .
Historical Cohort Study .
Incidence Study .
Studies, Cohort .
Studies, Incidence .
Study, Closed Cohort .
Study, Cohort .
Study, Concurrent .
Study, Historical Cohort .
Study, Incidence .
Cohort Analysis .
Closed Cohort Studies .
Concurrent Studies .
Historical Cohort Studies .
Incidence Studies .
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. .
0.40
 
General Surgery .
Surgery, General .
Surgery .
A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities. .
0.40
 
Phytotherapy .
Herbal Therapy .
Herb Therapy .
Use of plants or herbs to treat diseases or to alleviate pain. .
0.39
 
Prescription Drug Monitoring Programs .
Prescription Drug Monitoring Program .
Prescription Monitoring .
Monitoring, Prescription .
Prescription Monitorings .
Programs, usually run by state governments, that require pharmacists to collect and distribute data on the prescription and dispensation of CONTROLLED SUBSTANCES. They are intended to prevent the abuse of such substances by the patient, or their transfer to recreational users and drug dealers. .
0.39
 
Clinical Enzyme Tests .
Clinical Enzyme Test .
Enzyme Test, Clinical .
Test, Clinical Enzyme .
Tests, Clinical Enzyme .
Enzyme Tests, Clinical .
Enzyme Tests .
Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. .
0.39